StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$71.97−1.66 (-2.25%)

Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –

Utah Medical Products r&d expenses

Research and development expenses are spending on new products and technology.

Utah Medical Products's R&D Expenses for the twelve months ending Sep 30, 2026 was $662.00K. For fiscal 2025 it was $668.00K, down 17.8% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is $813.00K in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$668.00K-17.8%
FY2024Dec 31, 2024$813.00K+45.2%
FY2023Dec 31, 2023$560.00K+13.6%
FY2022Dec 31, 2022$493.00K-6.3%
FY2021Dec 31, 2021$526.00K+8.2%
FY2020Dec 31, 2020$486.00K+0.6%
FY2019Dec 31, 2019$483.00K+6.4%
FY2018Dec 31, 2018$454.00K+1.6%
FY2017Dec 31, 2017$447.00K-5.9%
FY2016Dec 31, 2016$475.00K-9.0%
FY2015Dec 31, 2015$522.00K+13.5%
FY2014Dec 31, 2014$460.00K-6.3%
FY2013Dec 31, 2013$491.00K-12.8%
FY2012Dec 31, 2012$563.00K–
FY2011Dec 31, 2011-$518.00K-230.5%
FY2010Dec 31, 2010$397.00K+10.0%
FY2009Dec 31, 2009$361.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$142.00K-15.0%
Q2 FY2026Jun 30, 2026$154.00K+14.1%
Q1 FY2026Mar 31, 2026$154.00K0.0%
Q4 FY2025Dec 31, 2025$212.00K+45.2%
Q3 FY2025Sep 30, 2025$167.00K+21.0%
Q2 FY2025Jun 30, 2025$135.00K+1.5%
Q1 FY2025Mar 31, 2025$154.00K+6.9%
Q4 FY2023Dec 31, 2023$146.00K+18.7%
Q3 FY2023Sep 30, 2023$138.00K+23.2%
Q2 FY2023Jun 30, 2023$133.00K-1.5%
Q1 FY2023Mar 31, 2023$144.00K+17.1%
Q4 FY2022Dec 31, 2022$123.00K-12.8%
Q3 FY2022Sep 30, 2022$112.00K-11.8%
Q2 FY2022Jun 30, 2022$135.00K+5.5%
Q1 FY2022Mar 31, 2022$123.00K-5.4%
Q4 FY2021Dec 31, 2021$141.00K+27.0%
Q3 FY2021Sep 30, 2021$127.00K+1.6%
Q2 FY2021Jun 30, 2021$128.00K+10.3%
Q1 FY2021Mar 31, 2021$130.00K-3.7%
Q4 FY2020Dec 31, 2020$111.00K-11.9%
Q3 FY2020Sep 30, 2020$125.00K-3.8%
Q2 FY2020Jun 30, 2020$116.00K+2.7%
Q1 FY2020Mar 31, 2020$135.00K+17.4%
Q4 FY2019Dec 31, 2019$126.00K+8.6%
Q3 FY2019Sep 30, 2019$130.00K+20.4%
Q2 FY2019Jun 30, 2019$113.00K-3.4%
Q1 FY2019Mar 31, 2019$115.00K+1.8%
Q4 FY2018Dec 31, 2018$116.00K+9.4%
Q3 FY2018Sep 30, 2018$108.00K+4.9%
Q2 FY2018Jun 30, 2018$117.00K-1.7%
Q1 FY2018Mar 31, 2018$113.00K-4.2%
Q4 FY2017Dec 31, 2017$106.00K-4.5%
Q3 FY2017Sep 30, 2017$103.00K-23.7%
Q2 FY2017Jun 30, 2017$119.00K0.0%
Q1 FY2017Mar 31, 2017$118.00K+7.3%
Q4 FY2016Dec 31, 2016$111.00K–
Q3 FY2016Sep 30, 2016$135.00K–
Q2 FY2016Jun 30, 2016$119.00K–
Q1 FY2016Mar 31, 2016$110.00K–

More Utah Medical Products figures

See a number that looks wrong?